TIDMVLG
RNS Number : 6837L
Venture Life Group PLC
17 May 2022
17(th) May 2022
VENTURE LIFE GROUP PLC
("Venture Life" "VLG" or the "Group")
Directorate Changes
Venture Life (AIM: VLG), a leader in developing, manufacturing
and commercialising products for the self-care market, announces
the appointment of Mr Paul McGreevy as Non-executive Chair of the
Company with immediate effect and consequent stepping down from the
Board of Dr. Lynn Drummond.
Mr McGreevy is an experienced and successful executive with over
30 years commercial experience in the consumer healthcare and
products industry. He has a strong track record of demonstrating
commercial success in Omni-channel sales across FMCG and is
experienced in franchise, wholesale and manufacturing, as well as
having established credentials in internationalising consumer
products and businesses.
Mr McGreevy spent his early career with Walgreen Boots Alliance
in the UK in R&D, sales, and marketing between 1993 & 1999.
This was followed by a period at Dewhirst Group as R&D and
Commercial Director. He joined The Body Shop International in 2004
as Global Product Director, then moving on to become Global
Operations Director, having additional responsibilities of R&D,
acquisitions and divestments. During his 10 years at The Body Shop,
he had responsibilities to over 70 markets and oversaw significant
growth and expansion of the business.
Since leaving The Body Shop, Mr McGreevy has pursued a
successful Non-executive career, as both Chair and Non-executive
Director of several international consumer product businesses. He
has current board appointments in consumer businesses with a focus
on brand, product development, operations, and R&D, with Danish
retail chain, Normal A/S, and cosmetics manufacturing company, SnJ
International Limited, whilst also also running his own consultancy
business, McGreevy Consulting Ltd.
Jerry Randall, CEO of Venture Life commented: " We are delighted
to have Paul join the Board of Venture Life Group as our new
Non-executive Chair. His extensive experience in the international
consumer healthcare market will be invaluable to us. In particular,
Paul's knowledge of the omni-channel approach to sales and
marketing is very pertinent to us as we seek to grow our brands and
our business through the many channels available to us in today's
market. As an experienced board Director and Chair, Paul brings
additional and considerable governance experience to our Board, and
we look forward to working with him.
On behalf of the whole Board, I also extend our deepest thanks
and gratitude to our outgoing Chair, Dr Lynn Drummond. Lynn has
been with us since before our IPO in 2014 and has helped us
navigate the difficult path of becoming a growing and sustainably
profitable consumer healthcare business on the public markets. We
thank Lynn for her time with us and wish her all the very best for
the future.
Paul McGreevy commented: " I am very excited to join such an
ambitious team, with a great portfolio of brands that provides a
solid foundation to accelerate our growth in the self-care sector.
VLG is well placed in a growing market to further develop its
brands, expand through acquisition, and increase its international
footprint."
Further information on Paul McGreevy
Paul Brian McGreevy (aged 54) has held the following
directorships in the past 5 years:
Current Directorships:
-- McGreevy Consulting Ltd
-- S&J International (UK) Limited
-- Normal A/S
Previous Directorships held in the past 5 years:
-- Age UK Lancashire
-- Kennelpak Group Ltd
-- Kennelpak Holdings Ltd
There is no further information on Paul McGreevy required to be
disclosed under Schedule Two, paragraph (g) of the AIM Rules for
Companies.
For further information, please contact:
Venture Life Group PLC +44 (0) 1344 578004
Jerry Randall, Chief Executive Officer
Daniel Wells, Chief Financial Officer
+44 (0) 20 7397
Cenkos Securities plc (Nomad and Joint Broker) 8900
Michael Johnson/Russell Kerr (Sales)
Stephen Keys/Camilla Hume (Corporate Finance)
+44 (0) 20 7496
Singer Capital Markets (Joint Broker) 3000
Jonathan Dighe (Sales)
Shaun Dobson/Alaina Wong (Corporate Finance)
About Venture Life ( www.venture-life.com )
Venture Life is an international consumer self-care company
focused on developing, manufacturing and commercialising products
for the global self-care market. With operations in the UK, Italy,
The Netherlands and Sweden, the Group's product portfolio includes
some key products such as the UltraDEX and Dentyl oral care product
ranges, the Balance Active range in the area of women's intimate
healthcare, the Lift and Glucogel product ranges for hypoglycaemia,
products for fungal infections and proctology, and dermo-cosmetics
for addressing the signs of ageing. Its products are sold in over
90 countries worldwide.
The products, which are typically recommended by pharmacists or
healthcare practitioners, are available primarily through
pharmacies and grocery multiples. In the UK and The Netherlands
these are supplied direct by the company to retailers, elsewhere
they are supplied by the Group's international distribution
partners.
Through its two Development & Manufacturing operations in
Italy and Sweden, the Group also provides development and
manufacturing services to companies in the medical devices and
cosmetic sectors.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
BOAKZGMKVVNGZZM
(END) Dow Jones Newswires
May 17, 2022 02:01 ET (06:01 GMT)
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Venture Life (LSE:VLG)
Storico
Da Apr 2023 a Apr 2024
